Tscan Therapeutics (TCRX)10% owner bought ~$290K
Lynx1 Capital Management LP, 10% owner at Tscan Therapeutics, bought ~$290K of Tscan Therapeutics shares.
- ~$290K
- Approx. value · 100K sh @ $2.90
- 5.36M
- Holds after · shares reported
- Traded
- Dec 13, 2024
- Filed
- Dec 16, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 15, 2024Insider10% owner purchased ~$4.1K of TCRX shares in the open market
- Dec 12, 2024Insider10% owner purchased ~$96K of TCRX shares in the open market
- Dec 13, 2024 · this disclosureInsider10% owner purchased ~$290K of TCRX shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Tscan Therapeutics
OQRO holds no insider, Congress, fund or contract record for Tscan Therapeutics dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TCRX page.
Other recent filings by Lynx1 Capital Management LP, 10% owner
- SEC Form 4 at Passage Bio (PASG)Jun 30, 2026
- SEC Form 4 at Tscan Therapeutics (TCRX)Dec 23, 2025
- SEC Form 4 at Tscan Therapeutics (TCRX)Dec 23, 2025
- SEC Form 4 at Tscan Therapeutics (TCRX)Dec 23, 2025
- SEC Form 4 at Neuphoria Therapeutics (NEUP)Oct 24, 2025
The full history of Lynx1 Capital Management LP, 10% owner is on the profile page.
How this filing works
Other disclosures at Tscan Therapeutics
- SEC Form 4Dec 23, 2025
- SEC Form 4Dec 23, 2025
- SEC Form 4Dec 23, 2025
- SEC Form 4May 21, 2025
- SEC Form 4May 21, 2025
- SEC Form 4Dec 16, 2024
Everything OQRO holds on this company is on its TCRX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
